Anuh Pharma Ltd

NSE: ANUHPHR · BSE: 506260 · Pharmaceuticals & Biotechnology · 20 announcements

Share price: ₹86.09
Market cap: ₹862.8 Cr
Revenue (annual): ₹771.7 Cr
Net profit (annual): ₹41.05 Cr
P/E (TTM): 19.5×Sector 47.4×
Promoter holding: 71.80%+0.00% QoQ
FII holding: 0.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Financial Results 4 Earnings Call 2 Annual General Meeting 2 Regulatory Approval 1 Promoter Reclassification 1 Management Change 1 Legal & Regulatory 1 Dividend 1 Debt & Borrowing 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

4 May 2026 21:36 IST BSE

Regulatory ApprovalAlfa Alert

Anuh Pharma Regulatory Approval

Anuh Pharma Ltd received WHO Prequalification approval for its anti-malarial API, Amodiaquine Hydrochloride USP. This approval allows the company to supply international markets, including WHO-procured and donor-funded programmes, consolidating its position as a preferred global supplier.

Read the filing ↗